Metropolis Healthcare Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹1384.2
- Today's High:
- ₹1430.3
- Open Price:
- ₹1414.1
- 52W Low:
- ₹1176.05
- 52W High:
- ₹1778.3599
- Prev. Close:
- ₹1418.25
- Volume:
- 7794
Company Statistics
- Market Cap.:
- ₹78.78 billion
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Metropolis Healthcare Limited had its IPO on under the ticker symbol 542650.
The company operates in the Other sector and Other industry. Metropolis Healthcare Limited has a staff strength of 0 employees.
Stock update
Shares of Metropolis Healthcare Limited opened at ₹1414.1 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹1384.2 - ₹1430.3, and closed at ₹1397.6.
This is a -1.46% slip from the previous day's closing price.
A total volume of 7,794 shares were traded at the close of the day’s session.
In the last one week, shares of Metropolis Healthcare Limited have increased by +1.42%.
Metropolis Healthcare Limited's Key Ratios
Metropolis Healthcare Limited has a market cap of ₹78.78 billion, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Metropolis Healthcare Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Metropolis Healthcare Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Metropolis Healthcare Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q0.33333333333333, Metropolis Healthcare Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Metropolis Healthcare Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Metropolis Healthcare Limited’s profitability.
Metropolis Healthcare Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Metropolis Healthcare Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹15.02 billion
- Total Liabilities
- ₹2.65 billion
- Operating Cash Flow
- ₹467.94 million
- Capital Expenditure
- ₹526.34 million
- Dividend Payout Ratio
- 0%
Metropolis Healthcare Limited ended 2024 with ₹15.02 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹15.02 billion while shareholder equity stood at ₹9.88 billion.
Metropolis Healthcare Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹2.65 billion in other current liabilities, 102421000.00 in common stock, ₹0 in retained earnings and ₹4.55 billion in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹1.20 billion. The company’s total short-term debt was ₹0 while long-term debt stood at ₹286.14 million.
Metropolis Healthcare Limited’s total current assets stands at ₹3.03 billion while long-term investments were ₹0 and short-term investments were ₹271.17 million. Its net receivables were ₹1.22 billion compared to accounts payable of ₹0 and inventory worth ₹445.91 million.
In 2024, Metropolis Healthcare Limited's operating cash flow was ₹467.94 million while its capital expenditure stood at ₹526.34 million.
Comparatively, Metropolis Healthcare Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹1397.6
- 52-Week High
- ₹1778.3599
- 52-Week Low
- ₹1176.05
- Analyst Target Price
- ₹
Metropolis Healthcare Limited stock is currently trading at ₹1397.6 per share. It touched a 52-week high of ₹1778.3599 and a 52-week low of ₹1778.3599. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹1394.86 and 200-day moving average was ₹1336.48 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.